报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | -1.5% | -161.98% | -188.46% | 122/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
2024-06-30 | -0.52% | -137.68% | -240.54% | 119/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
2024-03-31 | 0.37% | -13.95% | -83.41% | 107/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
2023-12-31 | 2.23% | -50.33% | -7.85% | 87/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
2023-09-30 | 2.42% | -49.16% | 75.36% | 101/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
2023-06-30 | 1.38% | -54.75% | 220.93% | 97/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
2023-03-31 | 0.43% | -73.13% | -90.42% | 112/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
2022-12-31 | 4.49% | -39.89% | -5.67% | 78/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
2022-09-30 | 4.76% | -50.57% | 56.07% | 68/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
2022-06-30 | 3.05% | -51.59% | 90.63% | 68/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
2022-03-31 | 1.6% | -43.26% | -78.58% | 72/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
2021-12-31 | 7.47% | -17.73% | -22.43% | 63/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
2021-09-30 | 9.63% | 2% | 52.86% | 35/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
2021-06-30 | 6.3% | 94.44% | 123.4% | 38/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
2021-03-31 | 2.82% | 2% | -68.94% | 48/160 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
2020-12-31 | 9.08% | -30.58% | 180.25% | 61/160 | 3.74% | 哈三联 | 27.17% | 行业排名> |
2020-06-30 | 3.24% | 2% | -75.23% | 73/160 | 4.24% | 汇宇制药 | 55.94% | 行业排名> |
2019-12-31 | 13.08% | -30.13% | -30.13% | 37/160 | 2.78% | 河化股份 | 45.32% | 行业排名> |
2018-12-31 | 18.72% | -30.31% | -30.31% | 18/160 | 7.09% | 汇宇制药 | 31.9% | 行业排名> |
2017-12-31 | 26.86% | 2% | 2% | 3/160 | 9.66% | 誉衡药业 | 35.56% | 行业排名> |